Celsius (NASDAQ:CELH) Price Target Raised to $45.00

Celsius (NASDAQ:CELH) had its target price boosted by Piper Sandler from $44.00 to $45.00 in a report published on Wednesday morning, Marketbeat Ratings reports. They currently have an overweight rating on the stock.

A number of other research firms have also commented on CELH. B. Riley reiterated a “buy” rating and issued a $49.00 price target (up previously from $44.00) on shares of Celsius in a research report on Friday, February 21st. Needham & Company LLC reaffirmed a “buy” rating and set a $47.00 target price on shares of Celsius in a research note on Thursday, May 29th. JPMorgan Chase & Co. raised their target price on Celsius from $39.00 to $44.00 and gave the stock an “overweight” rating in a research note on Friday, May 2nd. LADENBURG THALM/SH SH decreased their target price on Celsius from $62.00 to $58.00 and set a “neutral” rating for the company in a research note on Thursday, March 27th. Finally, Roth Mkm reaffirmed a “buy” rating and set a $38.00 target price on shares of Celsius in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $47.22.

Celsius Trading Up 1.3%

NASDAQ CELH opened at $40.60 on Wednesday. The business’s 50-day moving average price is $36.70 and its two-hundred day moving average price is $30.75. Celsius has a 12 month low of $21.10 and a 12 month high of $75.11. The firm has a market capitalization of $10.46 billion, a PE ratio of 92.27, a price-to-earnings-growth ratio of 2.90 and a beta of 1.65.

Celsius (NASDAQ:CELH) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.02). Celsius had a net margin of 10.70% and a return on equity of 51.89%. The company had revenue of $329.28 million during the quarter, compared to the consensus estimate of $349.09 million. During the same quarter last year, the firm posted $0.27 EPS. The company’s quarterly revenue was down 7.4% on a year-over-year basis. As a group, analysts forecast that Celsius will post 0.89 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Joyce Russell sold 4,000 shares of the business’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total transaction of $113,880.00. Following the completion of the transaction, the director now directly owns 19,106 shares in the company, valued at $543,947.82. The trade was a 17.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.55% of the stock is owned by company insiders.

Hedge Funds Weigh In On Celsius

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CELH. HM Payson & Co. grew its position in Celsius by 122.2% during the fourth quarter. HM Payson & Co. now owns 1,000 shares of the company’s stock worth $26,000 after buying an additional 550 shares in the last quarter. Westside Investment Management Inc. purchased a new position in Celsius during the first quarter worth about $32,000. Summit Securities Group LLC purchased a new position in shares of Celsius in the 1st quarter worth about $34,000. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Celsius by 255.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company’s stock worth $37,000 after purchasing an additional 750 shares in the last quarter. Finally, Blue Trust Inc. boosted its holdings in shares of Celsius by 32.8% in the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company’s stock worth $47,000 after purchasing an additional 441 shares in the last quarter. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.